BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 546789)

  • 1. Protection against experimental cholera by oral or parenteral immunization.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):594-8. PubMed ID: 546789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.
    Pierce NF; Cray WC; Sacci JB; Craig JP; Germanier R; Fürer E
    Infect Immun; 1983 Jun; 40(3):1112-8. PubMed ID: 6602094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.
    Pierce NF; Cray WC; Sircar BK
    Infect Immun; 1978 Jul; 21(1):185-93. PubMed ID: 711314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
    Pierce NF; Cray WC; Sacci JB
    Infect Immun; 1982 Aug; 37(2):687-94. PubMed ID: 6889574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid.
    Pierce NF
    Ciba Found Symp; 1976; (42):129-47. PubMed ID: 1086763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
    Stewart-Tull DE; Lucas C; Bleakley CR
    Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity.
    Kay RA; Ferguson A
    Immunology; 1989 Mar; 66(3):410-5. PubMed ID: 2703255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin.
    Pierce NF; Cray WC; Engel PF
    Infect Immun; 1980 Feb; 27(2):632-7. PubMed ID: 7380543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
    Sinha VB; Bhaskaran K
    Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
    Klipstein FA; Engert RF; Clements JD; Houghten RA
    Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of the intestinal mucosa to cholera toxoid.
    Pierce NF; Sack RB
    J Infect Dis; 1977 Aug; 136 Suppl():S113-7. PubMed ID: 894085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.
    Svennerholm AM; Holmgren J
    Infect Immun; 1976 Mar; 13(3):735-40. PubMed ID: 1270131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs.
    Pierce NF; Sack RB; Sircar BK
    J Infect Dis; 1977 Jun; 135(6):888-96. PubMed ID: 864285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
    Levine MM; Hughes TP; Young CR; O'Donnell S; Craig JP; Holley HP; Bergquist EJ
    Infect Immun; 1978 Jul; 21(1):158-62. PubMed ID: 101456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.
    Lange S; Holmgren J
    Acta Pathol Microbiol Scand C; 1978 Aug; 86C(4):145-52. PubMed ID: 696335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.